Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Clinical and Economic Outcomes of Adding Semaglutide to Standard of Care in Adult Pa... Read More
U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07586527) titled 'Adapted Mindfulness Training for Diabetic Patients With Impaired Hypoglycemia Awareness' on ... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination with Inte... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'Platelet-Rich Plasma with Hyaluronic Acid Injections for Post- Viral Olfactory loss. A double-blind... Read More
U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07586033) titled 'Prevalence and Functional Impact of Hand and Wrist Symptoms in Ice Hockey Players' on April ... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'Leveraging AS01-induced immune cell reprogramming to modulate immune dysregulation in rheumatoid ar... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'A Phase I/II open label study of DJI136, a DLL3-targeted CAR-T therapy, in adult patients with ES-S... Read More
Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'Beamion PANTUMOR 1: A Phase II, multicentre, multicohort, open-label trial to evaluate the efficacy... Read More